Treatment for diabetes in patients inappropriate for metformin therapy

CAFC
  • US 8,853,156 B2
  • Filed: 08/05/2009
  • Issued: 10/07/2014
  • Est. Priority Date: 08/06/2008
  • Status: Active Grant
First Claim
Patent Images

1. A method of treating and/or preventing metabolic diseases in a patient for whom metformin therapy is inappropriate due to at least one contraindication against metformin comprising orally administering to the patient a DPP-IV inhibitor wherein the contraindication is selected from the group consisting of:

  • renal disease, renal impairment or renal dysfunction, unstable or acute congestive heart failure, acute or chronic metabolic acidosis, and hereditary galactose intolerance.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×